abstract |
The present invention relates to the CCR3 receptor ligands of the general formula (I) or (IA) -within them favourably to the antagonists-, and to the salts and isomers thereof, to the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I) and (IA), and their salts and isomers and to the preparation of the compounds of the general formula (I) and (IA), and their salts and isomers. |